Excision repair cross-complementation group 1 protein overexpression as a predictor of poor survival for high-grade serous ovarian adenocarcinoma (Q84781471)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 21, 2010

Language	Label	Description	Also known as
English	Excision repair cross-complementation group 1 protein overexpression as a predictor of poor survival for high-grade serous ovarian adenocarcinoma	scientific article published on August 21, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Excision repair cross-complementation group 1 protein overexpression as a predictor of poor survival for high-grade serous ovarian adenocarcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

based on heuristic

inferred from title

author name string

Stefanie Scheil-Bertram

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Patricia Tylus-Schaaf

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Andreas du Bois

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Philipp Harter

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Matthias Oppitz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Nina Ewald-Riegler

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Annette Fisseler-Eckhoff

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20728204

20 June 2024

publication date

21 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

full work available at URL

https://api.elsevier.com/content/article/PII:S0090825810005470?httpAccept=text/xml

1 reference

10.1016/J.YGYNO.2010.07.018

https://api.crossref.org/works/10.1016/J.YGYNO.2010.07.018

20 June 2024

https://api.elsevier.com/content/article/PII:S0090825810005470?httpAccept=text/plain

1 reference

10.1016/J.YGYNO.2010.07.018

https://api.crossref.org/works/10.1016/J.YGYNO.2010.07.018

20 June 2024

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

325-331

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (A

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

ERCC5 is a novel biomarker of ovarian cancer prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

An ERCC1 splicing variant involving the 5'-UTR of the mRNA may have a transcriptional modulatory function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Protein expression levels of excision repair cross-complementation group 1 and xeroderma pigmentosum D correlate with response to platinum-based chemotherapy in the patients with advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

The relationship of platinum resistance and ERCC1 protein expression in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

ERCC1-immunoexpression does not predict platinum-resistance in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Validation of ERCC1-XPF immunodetection--letter

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Micropapillary serous carcinoma of the ovary: an immunohistochemical and mutational analysis of p53

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Potential role of the inactivated X chromosome in ovarian epithelial tumor development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Common Variants in RB1 Gene and Risk of Invasive Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.018

7 January 2021

Clear cell tumors have higher mRNA levels of ERCC1 and XPB than other histological types of epithelial ovarian cancer

12

1 reference

10.1016/J.YGYNO.2010.07.018

https://api.crossref.org/works/10.1016/J.YGYNO.2010.07.018

20 June 2024

Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications

29

1 reference

10.1016/J.YGYNO.2010.07.018

https://api.crossref.org/works/10.1016/J.YGYNO.2010.07.018

20 June 2024

Identifiers

10.1016/J.YGYNO.2010.07.018

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20728204%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84781471&oldid=2184660903"